Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 24, 2015 10:05 AM ET

Healthcare Equipment and Supplies

Company Overview of Bayer HealthCare LLC

Company Overview

Bayer HealthCare LLC develops, manufactures, and markets healthcare and medical products. The company offers blood glucose monitoring systems, diabetes self-care software, and lancing devices; and YAZ, a low-dose oral contraceptive. It also provides diagnostic testing for urinalysis, DCA, immunology, blood gas, and hematology; molecular and clinical chemistry testing to assess and manage health in a myriad of disease states, including cardiovascular, kidney and infectious diseases, oncology, and virology; and Bayer Migraine Formula, an over-the-counter medication designed to relieve migraine pain and accompanying symptoms, including nausea, phonophobia, and photophobia. The company offers an...

100 Bayer Boulevard

PO Box 915

Whippany, NJ 07981-0915

United States

Founded in 2002





Key Executives for Bayer HealthCare LLC

President and General Manager of Animal Health Division
President and General Manager, Animal Health Division, North America
President of Consumer Care Division
Sr. Vice President, Global Head, Product Supply -Biotech and Site Head
Bayer HealthCare Representative U.S.A.
Compensation as of Fiscal Year 2014.

Bayer HealthCare LLC Key Developments

Bayer HealthCare LLC Presents at ChinaBio Partnering Forum 2015, Apr-15-2015 09:30 AM

Bayer HealthCare LLC Presents at ChinaBio Partnering Forum 2015, Apr-15-2015 09:30 AM. Venue: Kerry Hotel, Pudong, Shanghai, China. Speakers: Hans Lindner, VP, Head of Global External Innovation and Alliances, Global Drug Discovery.

U.S. Food and Drug Administration Accepts Bayer HealthCare's Biologics License Application for Investigational Treatment Option in Hemophilia A

Bayer HealthCare announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Biologics License Application (BLA) for BAY 81-8973, a recombinant Factor VIII compound. Bayer is seeking FDA approval of the investigational compound, proposed trade name Kovaltry for the treatment of hemophilia A in children and adults. The BLA is based on results from the LEOPOLD (Long-Term Efficacy Open-Label Program in Severe Hemophilia A Disease) clinical trials, which evaluated BAY 81-8973 in adults and children using two- and three-times-per-week prophylaxis dosing regimens. The LEOPOLD Clinical Development Program consists of three multinational clinical trials designed to evaluate the pharmacokinetics, efficacy, and safety of BAY 81-8973 in subjects with severe hemophilia A.

Avivagen and Animal Health Division of Bayer Terminate U.S. Distribution Agreement for Oximunol Chewable Tablets

Avivagen Inc. announced the termination of its U.S. product distribution agreement with the Animal Health division of Bayer Healthcare LLC.

Similar Private Companies By Industry

Company Name Region
Encore Vision, Inc. United States
Alcon Surgical Inc. United States
VasCon, LLC United States
Windmill Cardiovascular Systems, Inc. United States
ReCor Medical, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Bayer HealthCare LLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at